Neurotrophic factors and the development of drugs to promote motoneuron survival

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 10-11, 1996, Pages 965-969

  Hughes, R A ^a   O'Leary, P D ^a   Hughes, Tony ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Drug design; Motoneuron; Neurotrophic factor; Protein structure

Indexed keywords

FIBROBLAST GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

CELL DEATH; CONFERENCE PAPER; DRUG DESIGN; DRUG DEVELOPMENT; HUMAN; MOTONEURON; NERVE CELL DEGENERATION;

EID: 0029835864     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01150.x     Document Type: Conference Paper

References (43)

1. Oppenheim RW. Cell death during development of the nervous system. Annu. Rev. Neurosci. 1991; 14: 453-501.
2. Patterson PH, Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell/Neuron 1993; 72/10 (Combined Suppl.): 123-37.
3. Caroni P, Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J. Cell Biol. 1990; 110: 1307-13.
4. Schnell L, Schneider R, Kolbeck R, Barde Y-A, Schwab ME. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994; 367: 170-3.
5. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 1994; 25: 1418-35.
6. Hamburger V. Regression versus peripheral control of differentiation in the control of motor hyperplasia. Am. J. Anat. 1958; 102: 365-410.
7. Hollyday M, Hamburger V. Reduction of the naturally occurring motor neuron loss by enlargement of the periphery. J. Comp. Neurol. 1976; 170: 311-20.
8. Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci. 1991; 15: 165-70.
9. Thoenen H, Hughes RA, Sendtner M. Trophic support of motoneurons: Physiological, pathophysiological and therapeutic implications. Exp. Neurol. 1993; 124: 47-55.
10. Ikeda K, Klinkosz B, Greene T et al. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol. 1995; 37: 505-11.
11. Henderson CE, Camu W, Mettling C et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993; 363: 266-70.
12. Hughes RA, Sendtner M, Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 1993; 36: 663-71.
13. Lohof AM, Ip NY, Poo M-M. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993; 363: 350-3.
14. Sendtner M, Carroll P, Holtmann B, Hughes RA, Thoenen H. Ciliary neurotrophic factor. J. Neurobiol. 1994; 25: 1436-53.
15. Sendtner M, Schmalbruch H, Stöckli KA, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 1992; 360: 541-2.
16. Robinson CJ. Neurotrophic factors: Novel therapeutics? Trends Biotech. 1994; 11: 496-8.
17. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen, H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993; 365: 27-32.
18. DeChiara TM, Vejsada R, Poueymirou WT et al. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995; 83: 313-22.
19. Arakawa Y, Sendtner M, Thoenen, H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines. J. Neurosci. 1990; 10: 3507-15.
20. Hughes RA, Sendtner M, Goldfarb M, Lindholm D, Thoenen H. Evidence that fibroblast growth factor 5 is a major muscle-derived survival factor for cultured spinal motoneurons. Neuron 1993; 10: 369-77.
21. Piehl F, Ru-Rong J, Hökfelt T, Lindholm D, Hughes RA. Fibroblast growth factors regulate calcitonin gene-related peptide mRNA expression in rat motoneurons after lesion and in culture. Eur. J. Neurosci. 1995; 7: 1739-50.
22. Oppenheim RW, Prevette D, Fuller F. The lack of effect of basic and acidic fibroblast growth factors on the naturally occurring death of neurons in the chick embryo. J. Neurosci. 1992; 12: 2726-34.
23. Nurcombe V, Ford MD, Wildschut JA, Bartlett PF. Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 1993; 260: 103-6.
24. Martinou J-C, Martinou I, Kato A. Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motoneurons in vitro. Neuron 1992; 8: 737-44.
25. Henderson CE, Phillips HS, Pollock RA et al. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994; 266: 1062-4.
26. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
27. Snider WD. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994; 77: 627-38.
28. Hébert JM, Rosenquist T, Götz J, Martin GR. FGF5 is a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell 1994; 78: 1017-25.
29. Klein, R, Smeye RJ, Wurst W et al. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neuronal death. Cell 1993; 75: 113-22.
30. Wong V, Arriaga R, Ip NY, Lindsay RM. The neurotrophins BDNF, NT-3 and NT-4/5, but not NGF, up-regulate the cholinergic phenotype of developing motoneurons. Eur. J. Neurosci. 1993; 5: 466-74.
31. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994; 265: 1107-10.
32. Dittrich F, Thoenen H, Sendtner M. Ciliary neurotrophic factor: Pharmacokinetics and acute phase response. Ann. Neurol. 1994; 35: 151-63.
33. Smythe ML, von Itzstein M. Design and synthesis of a biologically active antibody mimic based on an antibody-antigen crystal structure. J. Am. Chem. Soc. 1994; 116: 2725-33.
34. Chen S, Chrusciel RA, Nakanishi H et al. Design and synthesis of a CD-4 β-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes. Proc. Natl Acad. Sci. USA 1992; 89: 5872-6.
35. McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, Blundell TL. New protein fold revealed by 2.3Å resolution crystal structure of nerve growth factor. Nature 1991; 354: 411-14.
36. Robinson RC, Radziejewski C, Stuart DI, Jones EY. Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry 1995; 34: 4139-46.
37. Barbacid M. The trk family of neurotrophin receptors. J. Neurobiol. 1994; 25: 1386-403.
38. Ilag LL, Lönnerberg P, Persson H, Ibáñez CF. Role of the variable β-hairpin loop in determining biological specificities in neurotrophin family. J. Biol. Chem. 1994; 269: 19941-6.
39. Ibáñez CF, Ilag LL, Murray-Rust J, Persson H. An extended surface of binding to trk tyrosine kinase receptors in NGF and BDNF allows engineering of a multifunctional pan-neurotrophin. EMBO J. 1993; 12: 2281-93.
40. O'Leary PD, Hughes RA. Design and synthesis of conformationally constrained peptides that inhibit neuronal survival activity of brain-derived neurotrophic factor (BDNF). Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 1995; 2: 93.
41. McDonald NQ, Panayotatos N, Hendrickson WA. Crystal structure of dimeric human neurotrophic factor determined by MAD phasing. EMBO J. 1995; 14: 2689-99.
42. Robinson RC, Grey LM, Staunton D et al. The crystal structure and biological function of leukemia inhibitory factor: Implications for binding. Cell 1994; 77: 1101-16.
43. Zhu X, Komiya H, Chirino A et al. Three-dimensional structures of acidic and basic fibroblast growth factors. Science 1991; 251: 90-3.